• 🌎 Worldwide
    • 🇺🇸 U.S.
    • 🇨🇦 Canada
    • 🇬🇧 United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home Investments Marijuana Stocks

FSD Pharma Issues 40,000,000 Stock Options to Director Conditional on NASDAQ Listing

D.M.O. Newswire by D.M.O. Newswire
September 11, 2018
in Marijuana Stocks, Press Releases, Trading
TGOD files application for NASDAQ listing
161
SHARES
ShareShare

Toronto, ON — September 11, 2018 — /D.M.O. Newswire/ — FSD Pharma Inc. (“FSD”) (CSE:HUGE) (OTC:FSDDF), is pleased to announce the appointment of Dr. Raza Bokhari to its Board of Directors, effective immediately.

Dr. Bokhari currently serves as the Chairman & CEO of PCL, a global diagnostic provider of addiction screening and opioid prescription medication monitoring, including designer drugs and synthetic cannabinoids. He is also the managing partner of RBx Capital, LP.  Recipient of Philadelphia Business Journal’s “40 under 40” award, physician turned entrepreneur, Dr. Bokhari has over the past several years developed outstanding expertise in aggregating and accelerating life sciences and healthcare services companies. He has a vast knowledge base of developing creative concepts, implementing programs and forming strategic alliances. An effective “change agent”, with several years of experience and expertise in start-up and turn-around businesses, he is adept at turning around financially struggling companies. Dr. Bokhari recognizes the special role of private equity funds, venture capital money, and leveraged debt partners in executing accelerated growth trends in healthcare services and cancer diagnostics and therapeutics.

“We welcome Dr. Bokhari to the Board of Directors of FSD with his wealth of knowledge in international pharmaceuticals and we thank Mr. Donal Carroll, our current CFO for his work as a Board Member. Under current corporate law, Mr. Carroll has resigned his position to make room for our newest board member, Dr. Bokhari,” stated Thomas Fairfull, President and Chief Executive Officer of FSD. “I look forward to working with both of these experienced and talented professionals in their new capacities,” continued Mr. Fairfull.

Recognizing his zeal and passion for innovative entrepreneurship, Temple University’s Fox School of Business and Management nominated him “Entrepreneur in Residence” for the academic year 2001-2002. In October 2004, Philadelphia Business Journal (PBJ) named Dr. Bokhari’s company, Parkway Clinical Laboratories (PCL) as one of the top three small businesses to work for in the greater Philadelphia area. In 2001, he acquired financially distressed Lakewood Pathology Associates (LPA). During his term as the President and CEO until May 2007, the company grew ten times in revenue, expanded its client base to more than 25 states and created more than a hundred new jobs in the region. In June 2005, 2006, and 2007, PBJ also recognized LPA as one of the fastest growing top 25 companies in South Jersey. In 2006, LPA was included in the Philadelphia 100® fastest growing companies of the region. In May 2006, Dr. Bokhari sold LPA to a Chicago based PE fund, Water Street Healthcare Partners. The company received a $50 million equity commitment and produced an IRR of 3,684% (EBITDA x 8.3). In July 2008, he finalized the merger of PCL with Rosetta Genomics (ROSG), a global biotech R&D Company leading the microRNA revolution in cancer diagnostics and targeted therapeutics, to help execute Rosetta’s global commercialization efforts; the transaction produced an IRR of 137% (EBITDA x 27).

In April of 2016, Dr. Bokhari was named co-chair of the $100 Million centennial campaign to commemorate the 100 year anniversary of the Fox School of Business at Temple University, which he kicked off by making a $1 million leadership contribution. This follows his November 2006 $1 million gift to Temple University. In recognition of his support to Temple University and for promoting entrepreneurship in the region and beyond, the suite housing the Fox Business Innovation & Entrepreneurship Institute was named “Raza Bokhari Innovation & Entrepreneurship Suite”.

Dr. Bokhari is frequently retained as a consultant for due diligence by PE and VC funds focused in investing in life sciences/bio-tech and healthcare services companies. Regional, national and international media outlets and newspapers have either interviewed him or published his profile as an industry expert and community/civic leader. Dr. Bokhari has also spoken before professional organizations and academic institutions, including the US Congressional Caucus at Capitol Hill in Washington DC.

Dr. Bokhari has a Doctor of Medicine degree from the University of Punjab, Rawalpindi Medical College, and an Executive MBA from Temple University, Fox School of Business & Management. More information on Dr. Bokhari is available at www.razabokhari.com.

About FSD Pharma Inc. (CSE:HUGE) (OTC:FSDDF)

FSD Pharma owns, through its wholly-owned subsidiary FV Pharma Inc., a license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) which was originally granted on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development. Please visit www.fsdpharma.com for more information.

Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to establishment of an M&A committee. There is no assurance that any M&A transaction will be completed, nor any assurance as to the terms or timing of any such transaction.  M&A transactions are subject to a number of conditions including due diligence and third party consents.  Transactions of this kind are also subject to a number of risks, including competition from other parties, more particularly described in FSD’s public filings.  The forward-looking information contained in this press release is made as of the date hereof, and the Corporation is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither the Canadian Securities Exchange nor its regulation services provider accept responsibility for the adequacy or accuracy of this release.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: CSE:HUGEFSD Pharma Inc.licensed producerOTC:FSDDF

Get Real-Time Updates from MJobserver.com

Unsubscribe
D.M.O. Newswire

D.M.O. Newswire

D.M.O. Newswire is the cannabis industry's trusted news and press release dissemination service.

Related Posts

Bank of America Merrill Lynch Marijuana Stock Research Coverage
Investments

Bank of America Increases its SNDL Holdings

September 16, 2021
Bank of America Cannabis Stocks Investments
Investments

Bank of America Trims its Stake in Canopy Growth Corp.

September 16, 2021
Divvy Cannabis Prerolls Aleafia Stock News
Products

Aleafia Health Launches Everyday Cannabis Brand Divvy

April 7, 2021
German Cannabis Investing News
Press Releases

MediPharm Labs Achieves Export Milestone, Ships Cannabis Oil from Australia to Germany

April 6, 2021
Amended: Naturally Splendid Closes Private Placement and Secures Laboratory Facility
Investments

MediPharm Labs Reports Fourth Quarter and Full Year 2020 Results

March 31, 2021
INDIVA Ltd. (TSXV: NDVA) (OTC: NDVAF) Cannabis Stock News
Ontario

Indiva Reports Record Market Share for January 2021

February 9, 2021
Load More
Next Post

Time to Take Profits in FSD Pharma?

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🚨 Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

✉️ Subscribe to Our Newsletter!

* indicates required

🔎 Search Marijuana Stocks

📰 Recent News

  • J. Arnold Wealth Management Discloses New Stake in Cannabis ETF
  • Bank of America Increases its SNDL Holdings
  • The Lift & Co. Expo is back helping Canada build responsible, prosperous cannabis and psychedelics businesses
  • Bank of America Trims its Stake in Canopy Growth Corp.
  • Ballard Spahr Launches Cannabis Legislation Tracker to ID Industry Trends and Opportunities
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • 🇺🇸 United States
  • 🇨🇦 Canada
  • 🇬🇧 United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • 📅 Calendar
  • 📊 Databases
  • 📇 Directories
  • 🔔 RSS Feeds
  • 📺 Videos

Find Cannabis Business Services

  • ⚖️ Attorneys & Law Firms
  • 📊 Accountants & Accounting Firms
  • 💡 Consultants & Consulting Firms
  • 📲 Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • 👀 Advertise
  • 📣 DMO Newswire
  • 📇 List in Our Databases

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.